Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying client to any FEC committee. See the methodology glossary.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
Lobbying client · 103667
2 filings on record; a reported $500,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Registrants hired
Filings
| Registrant (lobbying firm) | Period | Reported quarterly amount | Filing type |
|---|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | Q2 2026 | $260,000 | Q2 |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | Q1 2026 | $240,000 | Q1 |
Source: Senate LDA filings.
Bills lobbied on
Bills named in this client's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- us-119-hr-1561 (not in corpus)
- us-119-hr-1708 (not in corpus)
- us-119-hr-1768 (not in corpus)
- Tyler’s Law (us-119-hr-2004)
- Ensuring Community Access to Pharmacist Services Act (us-119-hr-3164)
- us-119-hr-3269 (not in corpus)
- Improving Seniors’ Timely Access to Care Act of 2025 (us-119-hr-3514)
- us-119-hr-3789 (not in corpus)
- Health Care for Energy Workers Act of 2025 (us-119-hr-4122)
- us-119-hr-4581 (not in corpus)
- Biosimilar Red Tape Elimination Act (us-119-hr-5526)
- Fight Illicit Pill Presses Act (us-119-hr-5880)
- us-119-hr-6485 (not in corpus)
- PRESS Act (us-119-hr-7184)
- us-119-hr-7994 (not in corpus)
- Stop Pills That Kill Act (us-119-hr-8005)
- Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (us-119-hr-8646)
- us-119-hr-929 (not in corpus)
- Prior Authorization Accountability Act (us-119-hr-9396)
- Expedited Access to Biosimilars Act (us-119-hr-9661)
- us-119-s-1087 (not in corpus)
- us-119-s-1784 (not in corpus)
- Biosimilar Red Tape Elimination Act (us-119-s-1954)
- us-119-s-2372 (not in corpus)
- us-119-s-2426 (not in corpus)
- us-119-s-2658 (not in corpus)
- us-119-s-266 (not in corpus)
- us-119-s-3014 (not in corpus)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.